We treated mouse pancreatic and thyroid tumors with 2 known MNK inhibitors, CGP57380 (34) and eFT508 (Tomivosertib) (35), which effectively decreased p-eIF4ES209 levels in vivo (Figure 2, A and C). Here, ATP7A is linked to thyroid tumor.